• Something wrong with this record ?

Cognitive Performance and Exposure to Organophosphate Flame Retardants in Children: Evidence from a Cross-Sectional Analysis of Two European Mother-Child Cohorts

V. Rosolen, E. Giordani, M. Mariuz, M. Parpinel, V. Mustieles, L. Gilles, E. Govarts, L. Rodriguez Martin, K. Baken, G. Schoeters, O. Sepai, E. Sovcikova, L. Fabelova, J. Kohoutek, TK. Jensen, A. Covaci, M. Roggeman, L. Melymuk, J. Klánová, A....

. 2023 ; 11 (11) : . [pub] 20231024

Status not-indexed Language English Country Switzerland

Document type Journal Article

Grant support
733032 European Union
APVV-0571-12 Slovak Research and Development Agency
2014/47-SZU-11 Ministry of Health of the Slovak Republic
4004-00352B_FSS The Danish Research Council
NNF19OC0058266 Novo Nordisk Foundation, Denmark
NNF17OC0029404 Novo Nordisk Foundation, Denmark
2021-0173 Health Insurance Denmark

The knowledge of the effects of organophosphate flame retardants on children's neurodevelopment is limited. The purpose of the present research is to evaluate the association between exposure to organophosphate flame retardants and children's neurodevelopment in two European cohorts involved in the Human Biomonitoring Initiative Aligned Studies. The participants were school-aged children belonging to the Odense Child Cohort (Denmark) and the PCB cohort (Slovakia). In each cohort, the children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score of the Wechsler Intelligence Scale for Children, using two different editions. The children's urine samples, collected at one point in time, were analyzed for several metabolites of organophosphate flame retardants. The association between neurodevelopment and each organophosphate flame retardant metabolite was explored by applying separate multiple linear regressions based on the approach of MM-estimation in each cohort. In the Danish cohort, the mean ± standard deviation for the neurodevelopment score was 98 ± 12; the geometric mean (95% confidence interval (95% CI)) of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) standardized by creatinine (crt) was 0.52 μg/g crt (95% CI = 0.49; 0.60), while that of diphenyl phosphate (DPHP) standardized by crt was 1.44 μg/g crt (95% CI = 1.31; 1.58). The neurodevelopment score showed a small, negative, statistically imprecise trend with BDCIPP standardized by crt (β = -1.30; 95%CI = -2.72; 0.11; p-value = 0.07) and no clear association with DPHP standardized by crt (β = -0.98; 95%CI = -2.96; 0.99; p-value = 0.33). The neurodevelopment score showed a negative trend with BDCIPP (β = -1.42; 95% CI = -2.70; -0.06; p-value = 0.04) and no clear association with DPHP (β = -1.09; 95% CI = -2.87; 0.68; p-value = 0.23). In the Slovakian cohort, the mean ± standard deviation for the neurodevelopment score was 81 ± 15; the geometric mean of BDCIPP standardized by crt was 0.18 μg/g crt (95% CI = 0.16; 0.20), while that of DPHP standardized by crt was 2.24 μg/g crt (95% CI = 2.00; 3.52). The association of the neurodevelopment score with BDCIPP standardized by crt was -0.49 (95%CI = -1.85; 0.87; p-value = 0.48), and with DPHP standardized by crt it was -0.35 (95%CI = -1.90; 1.20; p-value = 0.66). No clear associations were observed between the neurodevelopment score and BDCIPP/DPHP concentrations that were not standardized by crt. No clear associations were observed with bis(1-chloro-2-propyl) phosphate (BCIPP) in either cohort, due to the low detection frequency of this compound. In conclusion, this study provides only limited evidence of an inverse association between neurodevelopment and exposure to BDCIPP and DPHP. The timing of exposure and effect modification of other organophosphate flame retardant metabolites and other substances should be the subject of further investigations that address this scientific hypothesis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23022657
003      
CZ-PrNML
005      
20240116163111.0
007      
ta
008      
240105s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/toxics11110878 $2 doi
035    __
$a (PubMed)37999530
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rosolen, Valentina $u Central Directorate for Health, Social Policies and Disability, Friuli Venezia Giulia Region, Via Cassa Di Risparmio 10, 34121 Trieste, Italy $1 https://orcid.org/0000000312925564
245    10
$a Cognitive Performance and Exposure to Organophosphate Flame Retardants in Children: Evidence from a Cross-Sectional Analysis of Two European Mother-Child Cohorts / $c V. Rosolen, E. Giordani, M. Mariuz, M. Parpinel, V. Mustieles, L. Gilles, E. Govarts, L. Rodriguez Martin, K. Baken, G. Schoeters, O. Sepai, E. Sovcikova, L. Fabelova, J. Kohoutek, TK. Jensen, A. Covaci, M. Roggeman, L. Melymuk, J. Klánová, A. Castano, M. Esteban López, F. Barbone
520    9_
$a The knowledge of the effects of organophosphate flame retardants on children's neurodevelopment is limited. The purpose of the present research is to evaluate the association between exposure to organophosphate flame retardants and children's neurodevelopment in two European cohorts involved in the Human Biomonitoring Initiative Aligned Studies. The participants were school-aged children belonging to the Odense Child Cohort (Denmark) and the PCB cohort (Slovakia). In each cohort, the children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score of the Wechsler Intelligence Scale for Children, using two different editions. The children's urine samples, collected at one point in time, were analyzed for several metabolites of organophosphate flame retardants. The association between neurodevelopment and each organophosphate flame retardant metabolite was explored by applying separate multiple linear regressions based on the approach of MM-estimation in each cohort. In the Danish cohort, the mean ± standard deviation for the neurodevelopment score was 98 ± 12; the geometric mean (95% confidence interval (95% CI)) of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) standardized by creatinine (crt) was 0.52 μg/g crt (95% CI = 0.49; 0.60), while that of diphenyl phosphate (DPHP) standardized by crt was 1.44 μg/g crt (95% CI = 1.31; 1.58). The neurodevelopment score showed a small, negative, statistically imprecise trend with BDCIPP standardized by crt (β = -1.30; 95%CI = -2.72; 0.11; p-value = 0.07) and no clear association with DPHP standardized by crt (β = -0.98; 95%CI = -2.96; 0.99; p-value = 0.33). The neurodevelopment score showed a negative trend with BDCIPP (β = -1.42; 95% CI = -2.70; -0.06; p-value = 0.04) and no clear association with DPHP (β = -1.09; 95% CI = -2.87; 0.68; p-value = 0.23). In the Slovakian cohort, the mean ± standard deviation for the neurodevelopment score was 81 ± 15; the geometric mean of BDCIPP standardized by crt was 0.18 μg/g crt (95% CI = 0.16; 0.20), while that of DPHP standardized by crt was 2.24 μg/g crt (95% CI = 2.00; 3.52). The association of the neurodevelopment score with BDCIPP standardized by crt was -0.49 (95%CI = -1.85; 0.87; p-value = 0.48), and with DPHP standardized by crt it was -0.35 (95%CI = -1.90; 1.20; p-value = 0.66). No clear associations were observed between the neurodevelopment score and BDCIPP/DPHP concentrations that were not standardized by crt. No clear associations were observed with bis(1-chloro-2-propyl) phosphate (BCIPP) in either cohort, due to the low detection frequency of this compound. In conclusion, this study provides only limited evidence of an inverse association between neurodevelopment and exposure to BDCIPP and DPHP. The timing of exposure and effect modification of other organophosphate flame retardant metabolites and other substances should be the subject of further investigations that address this scientific hypothesis.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Giordani, Elisa $u Department of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy $1 https://orcid.org/0000000235999462
700    1_
$a Mariuz, Marika $u Department of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy
700    1_
$a Parpinel, Maria $u Department of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy $1 https://orcid.org/0000000313094467
700    1_
$a Mustieles, Vicente $u Center for Biomedical Research, University of Granada, 18012 Granada, Spain $u Instituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain $u Consortium for Biomedical Research in Epidemiology and Public Health, 28029 Madrid, Spain $1 https://orcid.org/0000000220105438
700    1_
$a Gilles, Liese $u VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium $1 https://orcid.org/0000000230169750
700    1_
$a Govarts, Eva $u VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium $1 https://orcid.org/0000000260754862
700    1_
$a Rodriguez Martin, Laura $u VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
700    1_
$a Baken, Kirsten $u BrabantAdvies, Brabantlaan 3, 5216 TV 's-Hertogenbosch, The Netherlands
700    1_
$a Schoeters, Greet $u Department of Biomedical Sciences & Toxicological Centre, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, Wilrijk, 2610 Antwerp, Belgium $1 https://orcid.org/0000000265564814
700    1_
$a Sepai, Ovnair $u Toxicology Department, Science Group, UK Health Security Agency, Harwell Science and Innovation Campus, Didcot OX11 0RQ, UK
700    1_
$a Sovcikova, Eva $u Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
700    1_
$a Fabelova, Lucia $u Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia $1 https://orcid.org/0000000266339096
700    1_
$a Kohoutek, Jiři $u RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic
700    1_
$a Jensen, Tina Kold $u Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, Institute of Public Health, University of Southern Denmark, 5000 Odense, Denmark
700    1_
$a Covaci, Adrian $u Toxicological Centre, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium $1 https://orcid.org/0000000305271136
700    1_
$a Roggeman, Maarten $u Toxicological Centre, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium
700    1_
$a Melymuk, Lisa $u RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic $1 https://orcid.org/0000000160427688
700    1_
$a Klánová, Jana $u RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic
700    1_
$a Castano, Argelia $u National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain $1 https://orcid.org/0000000341527119
700    1_
$a Esteban López, Marta $u National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain $1 https://orcid.org/000000024527350X
700    1_
$a Barbone, Fabio $u Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy
773    0_
$w MED00196874 $t Toxics $x 2305-6304 $g Roč. 11, č. 11 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37999530 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240105 $b ABA008
991    __
$a 20240116163108 $b ABA008
999    __
$a ok $b bmc $g 2036352 $s 1209102
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 11 $c 11 $e 20231024 $i 2305-6304 $m Toxics $n Toxics $x MED00196874
GRA    __
$a 733032 $p European Union
GRA    __
$a APVV-0571-12 $p Slovak Research and Development Agency
GRA    __
$a 2014/47-SZU-11 $p Ministry of Health of the Slovak Republic
GRA    __
$a 4004-00352B_FSS $p The Danish Research Council
GRA    __
$a NNF19OC0058266 $p Novo Nordisk Foundation, Denmark
GRA    __
$a NNF17OC0029404 $p Novo Nordisk Foundation, Denmark
GRA    __
$a 2021-0173 $p Health Insurance Denmark
LZP    __
$a Pubmed-20240105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...